ACE and hydrops fetalis: For that purpose, angiotensin-converting enzyme (ACE) inhibitors, angiotensin II type I receptor blockers (ARBs), selected b-blockers (BB), aldosterone antagonists (AA), and inotropes might be recommended for patients with severe HF and reduced ejection fraction (HFrEF) [3].